doi:10.3969/j.issn.1673-8640.2024.04.015

Abstract

CLC Number:

R446.7

Figures/Tables 6

References 20

[1]	AKGÜN D, PERKA C, TRAMPUZ A, et al. Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics:results from a prospective cohort study[J]. Arch Orthop Trauma Surg, 2018, 138(5):635-642. DOI
[2]	LENGUERRAND E, WHITEHOUSE M R, BESWICK A D, et al. Risk factors associated with revision for prosthetic joint infection after hip replacement:a prospective observational cohort study[J]. Lancet Infect Dis, 2018, 18(9):1004-1014. DOI URL
[3]	YAN Q, KARAU M J, GREENWOOD-QUAINTANCE K E, et al. Comparison of diagnostic accuracy of periprosthetic tissue culture in blood culture bottles to that of prosthesis sonication fluid culture for diagnosis of prosthetic joint infection(PJI)by use of bayesian latent class modeling and idsa PJI criteria for classification[J]. J Clin Microbiol, 2018, 56(6):e00319.
[4]	SIMNER P J, MILLER S, CARROLL K C. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases[J]. Clin Infect Dis, 2018, 66(5):778-788. DOI PMID
[5]	BESSER J, CARLETON H A, GERNER-SMIDT P, et al. Next-generation sequencing technologies and their application to the study and control of bacterial infections[J]. Clin Microbiol Infect, 2017, 24(4):335-341. DOI URL
[6]	WILSON M R, NACCACHE S N, SAMAYOA E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing[J]. N Engl J Med, 2014, 370(25):2408-2417. DOI URL
[7]	DUAN H, LI X, MEI A, et al. The diagnostic value of metagenomic nextgeneration sequencing in infectious diseases[J]. BMC Infec Dis, 2021, 21(1):62. DOI
[8]	PARVIZI J, ZMISTOWSKI B, BERBARI E F, et al. New definition for peri-prosthetic joint infection:from the workgroup of the musculoskeletal infection society[J]. Clin Orthop Relat Res, 2011, 469(11):2992-2994. DOI URL
[9]	PARVIZI J, TAN T L, GOSWAMI K, et al. The 2018 definition of periprosthetic hip and knee infection:an evidence based and validated criteria[J]. J Arthroplasty, 2018, 33(5):1309-1314. DOI URL
[10]	邬兰, 张永, 曾宪涛. QUADAS-2在诊断准确性研究的质量评价工具中的应用[J]. 湖北医药学院学报, 2013, 32(3):201-208.
[11]	董文超, 昝强, 马建兵, 等. 宏基因组二代测序技术在假体周围感染中寻找病原菌的应用和价值[J]. 实用骨科杂志, 2022, 28(1):30-35.
[12]	于洋, 张少坤, 陆世涛, 等. 宏基因组二代测序技术在假体周围感染病原诊断中的应用[J]. 中华骨科杂志, 2021, 41(5):280-288.
[13]	黄子达, 张翀景, 李文波, 等. 宏基因组二代测序技术检测病原菌在诊断假体周围感染中的作用[J]. 中华骨科杂志, 2019, 39(15):944-953.
[14]	HUANG Z, LI W, LEE G C, et al. Metagenomic next-generation sequencing of synovial fluid demonstrates high accuracy in prosthetic joint infection diagnostics:mNGS for diagnosing PJI[J]. Bone Joint Res, 2020, 9(7):440-449. DOI URL
[15]	HE R, WANG Q, WANG J, et al. Better choice of the type of specimen used for untargeted metagenomic sequencing in the diagnosis of periprosthetic joint infections[J]. Bone Joint J, 2021, 103-B(5):923-930. DOI PMID
[16]	WANG C X, HUANG Z, FANG X, et al. Comparison of broad-range polymerase chain reaction and metagenomic next-generation sequencing for the diagnosis of prosthetic joint infection[J]. Int J Infect Dis, 2020,95:8-12.
[17]	CAI Y, FANG X, CHEN Y, et al. Metagenomic next generation sequencing improves diagnosis of prosthetic joint infection by detecting the presence of bacteria in periprosthetic tissues[J]. Int J Infect Dis, 2020,96:573-578.
[18]	FANG X, CAI Y, SHI T, et al. Detecting the presence of bacteria in low-volume preoperative aspirated synovial fluid by metagenomic next-generation sequencing[J]. Int J Infect Dis, 2020,99:108-116.
[19]	IVY M I, THOENDEL M J, JERALDO P R, et al. Direct detection and identification of prosthetic joint infection pathogens in synovial fluid by metagenomic shotgun sequencing[J]. J Clin Microbiol, 2018, 56(9):e00402-e00418.
[20]	HUANG Z D, ZHANG Z J, YANG B, et al. Pathogenic detection by metagenomic next-generation sequencing in osteoarticular infections[J]. Front Cell Infect Microbiol, 2020, 471(10):1-10.

纳入研究	年份	例数/例	样本类型	测序平台	诊断金标准	真阳性/例	假阳性/例	真阴性/例	假阴性/例
董文超等^[11]	^2022年	60	关节液/滑膜组织	Illumina NEXT Seq 550Dx	2018费城共识	40	7	2	11
于洋等^[12]	^2021年	33	关节液和组织微生物	Illumina NEXT Seq 550Dx	MSIS2011	13	1	8	11
黄子达等^[13]	^2019年	35	超声裂解液	BGISEQ-500	MSIS2011	20	0	0	15
HUANG等^[14]	^2019年	70	关节液	BGISEQ-500	MSIS2011	47	1	2	20
HE等^[15]	^2021年	59	超声裂解液、关节液、假体周围组织	BGISEQ-500	MSIS2011	38	1	2	18
WANG等^[16]	^2020年	63	关节液	BGISEQ-500	MSIS2011	43	1	2	17
CAI等^[17]	^2020年	44	假体周围组织	BGISEQ-500	MSIS2011	21	2	1	20
FANG等^[18]	^2020年	38	术前关节液	BGISEQ-500	MSIS2011	23	1	2	12

纳入研究	年份	例数/例	样本类型	测序平台	诊断金标准	真阳性/例	假阳性/例	真阴性/例	假阴性/例
董文超等^[11]	^2022年	60	关节液/滑膜组织	Illumina NEXT Seq 550Dx	2018费城共识	40	7	2	11
于洋等^[12]	^2021年	33	关节液和组织微生物	Illumina NEXT Seq 550Dx	MSIS2011	13	1	8	11
黄子达等^[13]	^2019年	35	超声裂解液	BGISEQ-500	MSIS2011	20	0	0	15
HUANG等^[14]	^2019年	70	关节液	BGISEQ-500	MSIS2011	47	1	2	20
HE等^[15]	^2021年	59	超声裂解液、关节液、假体周围组织	BGISEQ-500	MSIS2011	38	1	2	18
WANG等^[16]	^2020年	63	关节液	BGISEQ-500	MSIS2011	43	1	2	17
CAI等^[17]	^2020年	44	假体周围组织	BGISEQ-500	MSIS2011	21	2	1	20
FANG等^[18]	^2020年	38	术前关节液	BGISEQ-500	MSIS2011	23	1	2	12

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 20

Related Articles 15

Recommended Articles

Metrics

[1]	SHEN Jinjin, XUE Han, LI Jinfu, GAO Lifei, ZHENG Yehuan. Research progress on the factors of CYP2D6 genotyping [J]. Laboratory Medicine, 2024, 39(3): 291-297.
[2]	YANG Weiwei, YAO Liying, REN Chenchun, WANG Wenjing, ZHANG Haixia, LI Wen, LI Bo. Prenatal diagnosis result analysis of 884 fetuses with sex chromosomal abnormalities [J]. Laboratory Medicine, 2024, 39(2): 149-154.
[3]	LU Chao, HAN Huijuan, DI Hua, MU Yanchao. Pedigree analysis of dilated cardiomyopathy type 1S caused by MYH7 c.1574AG variation [J]. Laboratory Medicine, 2024, 39(2): 138-142.
[4]	WANG Yi, WU Yingting, CHEN Huifen, LI Guohua, BAO Shihua, DAI Jing, WANG Xuefeng. Genetic testing and analysis of pregnancy complicated with antithrombin deficiency [J]. Laboratory Medicine, 2024, 39(2): 132-137.
[5]	LU Yaya, PENG Huifang, WANG Jian, LOU Dan. Genetic analysis of Witteveen-Kolk syndrome caused by Sin3A variation [J]. Laboratory Medicine, 2024, 39(2): 126-131.
[6]	ZHU Hongwei, ZHANG Xueling, WANG Meidi, ZHENG Yingjuan. Case report and genetic analysis of Noonan syndrome type 10 caused by Arg284His variant of LZTR1 gene [J]. Laboratory Medicine, 2024, 39(2): 120-125.
[7]	JIANG Zhu, TAN Jianxin, TAN Juan, LUO Chunyu, XU Zhengfeng. Research progress in genetic diagnostic methods of fragile X syndrome [J]. Laboratory Medicine, 2024, 39(2): 107-113.
[8]	JING Mengxia, YU Yongguo. Clinical application of different molecular detection techniques in children's rare genetic diseases [J]. Laboratory Medicine, 2024, 39(2): 103-106.
[9]	ZHAO Eryu, LI Yujie, YU Ting, ZHANG Yan, YE Quan, LONG Yunxia, MA Xiaoyun, WANG Xiaoyan. Analysis of hereditary dysfibrinogenemia caused by FGG gene Ala315Gly missense mutation [J]. Laboratory Medicine, 2024, 39(2): 143-148.
[10]	ZHANG Feifei, WANG Jingwen, ZHANG Yuexin, ZHENG Dawei, MEN Xiang. Correlation between lncRNA MIR155HG and pulmonary function in patients with COPD and its auxiliary diagnosis value for AECODP [J]. Laboratory Medicine, 2024, 39(1): 31-36.
[11]	DAI Hongjian, CUI Haining, LI Yanfeng, CUI Hongmei. Promoting effect of miR-155-5p targeting ARID2 on oral squamous cell carcinoma [J]. Laboratory Medicine, 2024, 39(1): 87-94.
[12]	ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134.
[13]	YAN An, GUAN Xuhuizi, YU Tian, MIAO Gang, ZHAO Yanyang. Identification of a new susceptibility gene variant EPB41L4A rs1455421289 in Chinese PTC patients by WES [J]. Laboratory Medicine, 2023, 38(11): 1009-1014.
[14]	GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206，miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068.
[15]	ZHU Qian, ZHU Lifang, MA Caiyun, YAO Jie. Relation of serum miR-140-5p and PGC-1α mRNA expression with vascular cognitive impairment in acute ischemic stroke patients [J]. Laboratory Medicine, 2023, 38(11): 1069-1074.